Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Biomet Shoots From The Hip With Ceramic Offering, Mobile Bearing Knees

This article was originally published in The Gray Sheet

Executive Summary

Biomet will submit a 510(k) for a total mobile bearing version of its Vanguard knee implant, contingent on FDA downclassification, according to VP-Corporate Development & Communications Greg Sasso

You may also be interested in...



Biomet Gains Diamond Coating Technology For Total Hip, Knee Arthroplasty

Diamicron's polycrystalline diamond surface will be tested on total hip implants in clinical trials by mid-2005, Biomet estimates

Biomet Gains Diamond Coating Technology For Total Hip, Knee Arthroplasty

Diamicron's polycrystalline diamond surface will be tested on total hip implants in clinical trials by mid-2005, Biomet estimates

Mobile Bearing Knees Get FDA Panel Nod For Class II; J&J Sees Competition

Unicompartmental mobile bearing knees should be reclassified as Class II with special controls despite a lack of clinical safety data addressing implant wear and fracture, according to FDA's Orthopaedic & Rehabilitation Devices Panel

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020415

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel